William Tanner, Ph.D.
Prior to joining Brookline, Dr. Bill Tanner spent more than 20 years as a Senior Biotechnology Equity Research Analyst, with the preponderance of his tenure at leading Wall Street healthcare investment banks such as Vector Securities, SG Cowen, Leerink Swann and Lazard Capital Markets. His research coverage encompassed a broad range of market capitalizations and business models and, while Director of Research at Leerink Swann, he helped guide the evolution of research categories. As a Senior Capital Markets Advisor, Dr. Tanner applies his biotech sector experience to support Brookline's financing and advisory business activities.
Dr. Tanner received a Ph.D. from Texas A&M University and was a National Research Service Award recipient from the NIH at the Washington University School of Medicine where his research focused on processes of signal transduction.